Alpha 2.0
Login Register
» Authors » Aaron Fleischauer

Aaron Fleischauer

Explore the profile of Aaron Fleischauer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 778
Followers 0
Related Specialties
General Medicine
Public Health
Infectious Diseases
Top 10 Co-Authors
Mikhail Hoskins
Zack Moore
Heather M Scobie
Enaholo Omoike
Komal Patel
Erica Wilson
Buddhi P Tilakaratne
Benjamin J Silk
Emma Stanislawski
Amelia G Johnson
Published In
MMWR Morb Mortal Wkly Rep
Public Health Rep
J Infect Dis
N C Med J
Sex Transm Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Notes from the Field: Suspected Outbreak of Trichinellosis Associated with Undercooked Bear Meat - North Carolina, November 2023
Gowler C, Lee N, Morrison T, Mears V, Williams C, Fleischauer A, et al.
MMWR Morb Mortal Wkly Rep . 2024 Oct; 73(40):906-907. PMID: 39388384
No abstract available.
2.
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period
Sternberg M, Johnson A, King J, Ali A, Linde L, Awofeso A, et al.
PLoS One . 2023 Sep; 18(9):e0291678. PMID: 37729332
Background: SARS-CoV-2 Omicron variants have the potential to impact vaccine effectiveness and duration of vaccine-derived immunity. We analyzed U.S. multi-jurisdictional COVID-19 vaccine breakthrough surveillance data to examine potential waning of...
3.
Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022
Ma K, Dorabawila V, Leon T, Henry H, Johnson A, Rosenberg E, et al.
MMWR Morb Mortal Wkly Rep . 2023 Jun; 72(25):683-689. PMID: 37347715
Although reinfections with SARS-CoV-2 have occurred in the United States with increasing frequency, U.S. epidemiologic trends in reinfections and associated severe outcomes have not been characterized. Weekly counts of SARS-CoV-2...
4.
Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023
Johnson A, Linde L, Payne A, Ali A, Aden V, Armstrong B, et al.
MMWR Morb Mortal Wkly Rep . 2023 Jun; 72(24):667-669. PMID: 37319029
No abstract available.
5.
Legionnaires' Disease Outbreak Associated With a Hot Tub Display at the North Carolina Mountain State Fair, September 2019
Donovan C, MacFarquhar J, Wilson E, Sredl M, Tanz L, Mullendore J, et al.
Public Health Rep . 2023 Mar; 139(1):79-87. PMID: 36971250
Objectives: On September 23, 2019, the North Carolina Division of Public Health identified a legionellosis increase in western North Carolina; most patients had recently attended the North Carolina Mountain State...
6.
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022
Johnson A, Linde L, Ali A, DeSantis A, Shi M, Adam C, et al.
MMWR Morb Mortal Wkly Rep . 2023 Feb; 72(6):145-152. PMID: 36757865
On September 1, 2022, CDC recommended an updated (bivalent) COVID-19 vaccine booster to help restore waning protection conferred by previous vaccination and broaden protection against emerging variants for persons aged...
7.
Characteristics of an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury-North Carolina, 2019
Tanz L, Christensen A, Knuth K, Hoffman M, Dandeneau D, Koehler K, et al.
N C Med J . 2021 Nov; 82(6):384-392. PMID: 34750211
In August 2019, the North Carolina Division of Public Health (NCDPH) began investigating e-cigarette, or vaping, product use-associated lung injury (EVALI) cases as part of a national response. We describe...
8.
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021
Scobie H, Johnson A, Suthar A, Severson R, Alden N, Balter S, et al.
MMWR Morb Mortal Wkly Rep . 2021 Sep; 70(37):1284-1290. PMID: 34529637
COVID-19 vaccine breakthrough infection surveillance helps monitor trends in disease incidence and severe outcomes in fully vaccinated persons, including the impact of the highly transmissible B.1.617.2 (Delta) variant of SARS-CoV-2,...
9.
SARS-CoV-2 testing in North Carolina: Racial, ethnic, and geographic disparities
Brandt K, Goel V, Keeler C, Bell G, Aiello A, Corbie-Smith G, et al.
Health Place . 2021 Apr; 69:102576. PMID: 33915376
SARS-CoV-2 testing data in North Carolina during the first three months of the state's COVID-19 pandemic were analyzed to determine if there were disparities among intersecting axes of identity including...
10.
National Public Health Burden Estimates of Endocarditis and Skin and Soft-Tissue Infections Related to Injection Drug Use: A Review
See I, Gokhale R, Geller A, Lovegrove M, Schranz A, Fleischauer A, et al.
J Infect Dis . 2020 Sep; 222(Suppl 5):S429-S436. PMID: 32877563
Background: Despite concerns about the burden of the bacterial and fungal infection syndromes related to injection drug use (IDU), robust estimates of the public health burden of these conditions are...